Atlas Trials

Study Of Eltrombopag in Healthy Subjects and Volunteers With Mild, Moderate or Severe Hepatic Impairment

Clinical trial NCT00359463 · COMPLETED

Trial details

NCT number
NCT00359463
Sponsor
GlaxoSmithKline
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Purpura, Thrombocytopaenic, Idiopathic
Start date
2006-04-18
Primary completion
2007-03-07
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.